Document Detail

Obesity and the risk of late mortality after aortic valve replacement with small prosthesis.
Jump to Full Text
MedLine Citation:
PMID:  23856275     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Whether obesity is related to late mortality with implantation of small aortic prosthesis remains to be clarified. This study was aimed to evaluate the effect of obesity on late survival of patients after aortic valve replacement (AVR) with implantation of small aortic prosthesis (size <= 21 mm).
METHODS: From January 1998 to December 2008, 307 patients in our institution who underwent primary AVR with smaller prostheses survived the 30 days after surgery. Patients were defined as normal if body mass index (BMI) was < 24 kg/m2, as overweight if BMI 24--27.9 kg/m2, and as obese if BMI >= 28 kg/m2. Data of New York Heart Association (NYHA) functional classification, left ventricular ejection fraction (LVEF), effective orifice area index (EOAI), and left ventricular mass index(LVMI) of the patients collected at the 3rd month(M), 6th M, 1st year(Y), 3rd Y, 5th Y, 8th Y after operation respectively.
RESULTS: By multivariable analysis, obesity was an independent factor of late mortality (hazard ratio [HR]:1.62; P = 0.01). The obesity and overweight group had more poor survival (p < 0.001) and higher proportion of NYHA class III/IV (p < 0.01) compared with the normal group. Lower EOAI and higher LVMI were found in obesity and overweight group, but we saw no significant difference about LVEF among the three groups.
CONCLUSIONS: Obesity was associated with increased late mortality of patients after AVR with implantation of small aortic prosthesis. Being obese or and overweight may also affect the NYHA classification, even in the longer term. EOAI should be improved where possible, as it may reduce late mortality and improve quality of life in obese or overweight patients.
Authors:
Biao Wang; Hongyang Yang; Shuming Wu; Guangqing Cao; Hongling Yang
Related Documents :
6492305 - The natural history of isolated carotid siphon stenosis.
11254835 - S-100beta protein levels do not correlate with stroke in patients undergoing carotid en...
22789675 - Impact of ileal pouch-anal anastomosis on the surgical outcome of orthotopic liver tran...
17895105 - Reduced stroke risk in patients with compromised cerebral blood flow reactivity treated...
9880125 - The cost and cardioprotective effects of enalapril in hypertensive patients with left v...
24095235 - A novel repair method for the treatment of acute achilles tendon rupture with minimally...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-7-15
Journal Detail:
Title:  Journal of cardiothoracic surgery     Volume:  8     ISSN:  1749-8090     ISO Abbreviation:  J Cardiothorac Surg     Publication Date:  2013 Jul 
Date Detail:
Created Date:  2013-7-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101265113     Medline TA:  J Cardiothorac Surg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  174     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): J Cardiothorac Surg
Journal ID (iso-abbrev): J Cardiothorac Surg
ISSN: 1749-8090
Publisher: BioMed Central
Article Information
Download PDF
Copyright ©2013 Wang et al.; licensee BioMed Central Ltd.
open-access:
Received Day: 11 Month: 11 Year: 2012
Accepted Day: 25 Month: 6 Year: 2013
collection publication date: Year: 2013
Electronic publication date: Day: 15 Month: 7 Year: 2013
Volume: 8First Page: 174 Last Page: 174
PubMed Id: 23856275
ID: 3765481
Publisher Id: 1749-8090-8-174
DOI: 10.1186/1749-8090-8-174

Obesity and the risk of late mortality after aortic valve replacement with small prosthesis
Biao Wang1 Email: wangbiao305@163.com
Hongyang Yang1 Email: 690609619@qq.com
Shuming Wu1 Email: wushuming126@163.com
Guangqing Cao1 Email: cgq200844@163.com
Hongling Yang1 Email: yanzy055@yeah.net
1Department of Cardiovascular Surgery Qilu Hospital, Shandong University, Jinan, China

Background

The aortic annulus of Chinese individuals is typically smaller than that of people of European descent, and thus our hospital in china treats many patients who have a small aortic annulus in aortic valve replacement (AVR). Techniques developed to expand the annulus [1-3] were rarely applied in clinical circumstances because these techniques may increase the complexity and risk in an operation [4,5]; most surgeons prefer to use a small aortic prosthesis instead of expanding the annulus. Yet the use of a small aortic prosthesis may be associated with obstruction of left ventricular output, resulting in a higher transvalvular gradient and patient-prosthesis mismatch (PPM) [6]. Studies [7,8] have demonstrated that mortality was higher in patients receiving a small aortic prosthesis; Further complicating the issue, there was a rapid increase in the obese population in recent decades, and obesity has become an important factor that seriously affects the health of Chinese people [9]. However, it is unclear whether obesity is related to later mortality in AVR. Here we report 307 patients from a single center in China who underwent AVR with small prostheses (size ≤ 21 mm); our long-term follow-up study investigated if obesity was an independent predictor of long-term mortality for these patients after AVR.


Methods
Patients

From January 1998 through December 2008, a total of 328 patients underwent primary AVR (size ≤ 21 mm) at the Department of cardiovascular surgery of Qilu Hospital, Shandong University, Jinan, China. 21 (6.4%) of the 328 patients who died within 30 days following surgery were excluded, so the study population was composed of 307 patients (mean age 56 ± 12.6), 58.3% (n = 179) are females. Etiology was rheumatic disease in 44.3% (n = 136) patients, congenital bicuspid valve in 25.5% (n = 78) patients, degenerative calcific disease in 22.4% (n = 69) patients, and endocarditis in 7.8% (n = 24) patients. 40.7% (n = 125) received bioprosthesis. Preoperative coronary angiography was performed in all patients aged ≥ 50 years old and in all patients with angina or in whom coronary artery disease was suspected on a clinical basis. 17.5% (n = 54) underwent concomitant coronary artery bypass graft surgery (CABG). The study was approved by the ethics review committee for human studies at the School of Medicine, Shandong University.

Data collection

Pre-operative and operative data were prospectively collected and validated (Table 1). Follow-up information was available in all 307 patients. Most (68.4%, n = 210) were followed up regularly at our institution; telephone, E-mail, post, or out-patient interviews (29%, n = 89) were conducted with patients or first-degree relatives, to confirm mortality and get related data including weight, height, symptom, capacity for action and results of Two-dimensional and Dopper echocardiography; mortalities among the remaining patients (1.8%, n = 8) were determined using national death and survival data registry.

BMI definition

We adopted the most commonly used BMI classification system for adults in China [10]. Patients were classified as normal weight if BMI was < 24 kg/m2, as overweight if BMI 24–27.9 kg/m2, and as obese if BMI ≥ 28 kg/m2. The cohort was divided into 3 groups according to BMI: normal weight (n = 185, 60.2%), overweight (n = 94, 30.6%), and obese (n = 28, 9.2%).

Statistical methods

Pre-operative and operative data are expressed as mean ± SD or percentages. Repeated analysis of variance (ANOVA) measures were used to test the significance of changes in data in different groups of the study; the Sheffe post-hoc test was utilized for multiple comparisons. The chi-square analysis or Fisher exact test was used to compare categorical data. Cumulative probability of survival was analyzed by constructing Kaplan-Meier curves among patients in three groups, and inter-group comparisons were performed using the long-rank test. Cox proportional-hazards regression models were used to determine whether overweight and obesity were associated with survival after AVR. The related variables were entered into the Cox analyses of observed survival. Significant (P ≤ 0.1) variables on univariate analysis were reentered in a multivariable model examining predictors of survival. A propensity score was calculated using a logistic regression analysis that identified variables, that may be associated with BMI. Variables included in the logistic regression analysis were: sex, age, body surface area (BSA), diabetes mellitus, systemic hypertension, chronic lung disease, EOAI, and cardiac pulmonary bypass (CPB) time. The propensity score was then incorporated into subsequent proportional-hazards models. Results were expressed as the hazard ratio (HR) and 95% of confidence interval (CI). All statistical analyses were carried out using SPSS 17.0 (SPSS, Chicago, IL).


Results

In this study, normal BMI (< 24 kg/m2) was present in 62.5% of the patients (n = 185), overweight BMI (24–27.9 kg/m2) presented in 30.6% (n = 94) and obesity BMI (≥ 28 kg/m2) in 9.2% (n = 28). Pre-operative and operative data are shown in Table 1. Compared with the normal group, those patients in overweight and obesity groups had a smaller EOAI, a larger BSA, lower prevalence of AF, and a higher prevalence of diabetes mellitus, systemic hypertension, chronic lung disease, as well as concomitant coronary artery bypass grafting (CABG). The obesity group displayed a higher proportion of female patients than the overweight group, and predominant insufficiency was more frequent and CBP time longer in obesity group than the other two groups. We found no significant difference in the variables of age, NHYA class and prosthesis type (biological or mechanical) among three groups.

Impact of BMI on morality

Mean overall follow-up duration was 4.7 ± 2.8 years (median, 4.1 years; range: 0.2-10 years). 68 deaths were observed during follow-up. The overall survival rate was 81.5% ± 2.6% at 5 years and 54.3% ± 1.4% at 10 years (Figure 1A). For obese patients, 5-year survival (65.1% ± 1.8%) and 10-year survival (31.6% ± 1.4%) were significantly lower than those of patients with normal BMI (5-year survival: 85.2% ± 3.6%; 10-year survival: 65% ± 2.2%; P = 0.007; Figure 1B). The obese group also had significantly lower survival than the overweight group (5-years survival: 74.8% ± 3.1%; 10-years survival: 52.2% ± 2.0%; P = 0.01). Difference in survival between the normal and overweight groups was also statistically significant (P = 0.03), with the overweight group having a lower survival rate.

Predictors of mortality

According to univariate analysis (Table 2), the predictors of late post-operative mortality were old age, poor cardiac function, reduced LV ejection fraction (LVEF), suffering from diabetes, hypertension, chronic lung disease and atrial fibrillation (AF), concomitant CABG, use of a mechanical prosthesis, EOAI (≤0.85 cm2/m2), and obesity, with obesity presenting a higher level of statistical significance (HR: 1.84; 95% CI: 1.46 to 2.26; P < 0.001). Overweight also tended to be associated with higher mortality by univariate analysis (HR: 0.92; 95% CI: 0.71 to 1.15; P =0.01). For multivariate analysis (Table 2), after adjustment of the variables with a p ≤ 0.1 on univariate analysis, the following variables were rendered not independently associated with long-term survival: poor cardiac function, concomitant CABG, and use of a mechanical prosthesis; overweight also failed to be an independent predictor (HR: 0.64; 95% CI: 0.50 to 0.81; P =0.45), but obesity remained significantly associated with increased mortality (HR: 1.60; 95% CI: 0.32 to 1.91; P =0.008). After further adjustment for propensity score, the following variables were still independent predictors: old age (HR: 0.21; 95% CI: 1.04 to 1.10; P < 0.001), reduced LVEF (HR: 1.28; 95% CI: 1.09 to 1.51; P < 0.001), suffering from diabetes (HR: 1.02; 95% CI: 0.75 to 1.32; P =0.01, hypertension (HR: 1.01; 95% CI: 0.79 to 1.33; P < 0.001), chronic lung disease (HR: 1.30; 95% CI: 1.03 to 1.60; P = 0.003), EOAI (HR: 1.26; 95% CI: 1.09 to 1.44; P = 0.005) and obesity (HR: 1.62; 95% CI: 1.33 to 1.93; P = 0.01).


Discussion

Here we reported the long-term follow-up with patients who underwent aortic prosthesis replacement with smaller prosthesis (size ≤ 21 mm) in china. A notable finding was produced that obesity (BMI ≥ 28 kg/m2) was an independent predictor of late mortality in patients undergoing AVR with small prosthesis. Obesity group and overweight group had poor survival and higher proportion of NYHA Function III/IV compared to normal group.

Review of previous studies

There have been some different opinions in the published reports about the impact of BMI on outcomes after AVR, but specialized research on AVR with small prosthesis was scarce. Several studies demonstrated that BMI is an independent predictor of mortality and clinic events after AVR. Parwis [11] revealed obesity as an independent predictor of hospital and longer mortality in patients who underwent valve surgery. William [12] studied patients having AVR for AS with or without concomitant coronary artery bypass grafting and revealed a better survival in patients with low BMI compared to patients with higher BMI. On the other hand, others failed to found a significant effect of BMI on post-operative outcomes. Vinod [13] reported patients with BMI 24 or less are at significantly increased risk of in-hospital and long-term mortality after cardiac valvular surgery. This high-risk patient population warrants careful risk stratification and options for less-invasive valve therapies. Robert [14] found Increasing BMI has no independent association with worsened outcomes in the short or long term, and overweight patients have a survival benefit after surgery. So the relationship of BMI and long-term survival after AVR was controversial. The long-term survival research about BMI in small aortic root is rarely reported.

Impact of BMI on long-term mortality and NYHA classification

It is important to note that there may be some differences in AVR between China and Western countries; it is unknown whether this could affect the results of the research. For example, rheumatic disease accounted for the major etiology in this cohort although occurrence of degeneration was on the rise; mechanical valves were mostly used; and patients were younger and had less concomitant CABG.

In this study, we determined that obesity raised the long-term mortality, implying that higher BMI means higher risk of adverse outcomes for patients with small aortic prosthesis replacement. These results are consistent with some previous studies [11,12]. In addition, a higher proportion of patients with poor cardiac function were observed in the obesity group at one year after surgery, and that distinction increased over time. These findings suggest that high BMI is a possible indicator of poor long-term quality of life for patients with small aortic roots. Numerous earlier studies [15,16] concluded that NYHA class of the patients could be ameliorated within a short period after operation. Nevertheless those studies they failed to keep up with its change in subsequent years after AVR.

The long-term outcome of EOAI, LVEF, LVMI

Several factors such as EOAI, LVEF and LVMI may directly contribute to a higher class of NHYA class [17,18] in obesity and overweight group. We expelled LVEF from the list due to its insignificant change along with BMI increase. In contrast, EOAI and LVMI turned out to be related with BMI in our investigation. As a result, EOAI may associate with cardiac function and influence postoperative life quality. We also found EOAI to be also an independent predictor of late mortality in this research, which was in accordance with previous researches [17-20]. EOAI ≤ 0.85 cm2/m2 (considered as PPM) [21] could lead to increased late mortality after AVR, and that’s why PPM should be avoided in patients with small aortic roots. It’s a challenge for surgeons to select the optimal type and size of prosthesis, so that proper EOAI could be maintained in obese patients. Although suprannular stentless valves have been applied in clinic recent years to increase EOAI and prevent PPM, there have been some discrepancies in the results [22-27]. Annulus enlarging techniques, including Nicks procedure [1], the Manouguian technique [2] and the Konno procedure [3], allow for the implantation of prosthetic valves 1 or 2 size larger than the original size of the aortic annulus [28], and many studies have been frequently reported with good results, but some authors have reported increased operative mortality [28], so there is still no agreement about annulus enlarging techniques.

Clinical implications

Why does obesity affect the late mortality and NYHA functional class in patients with implantation of small aortic prosthesis? We attempted to throw light upon the question in the following aspects: obesity-related diseases, operation techniques and postoperative lifestyle. Being overweight or obese were associated with increased risk of underlying disease such as diabetes [29], hypertension [30], coronary artery disease [31,32] and other chronic diseases [33-35], which may increase the mortality in the long-term. We indicated in this research that diabetes, systemic hypertension and chronic lung disease were independent predictors of late morality in patients undergoing AVR with small prosthesis. So obesity-related disease should be taken into consideration in advance to evaluate risk of surgery and predict long-term outcomes for the patients.

According to the results in our study, we should reconsider the role of annulus-enlarging techniques even though they are often accompanied by increased morbidity and mortality after AVR. Such techniques may be meaningful to recommend as the best choice for the patients with obesity and relatively small aortic annulus requiring AVR, but implantation with small prosthesis, especially in younger patients [36], can effectively increase the EOAI and improve the long-term outcome and life quality. So in the future we should work to perfect annulus-enlarging techniques, including reducing the cross-clamp time and the occurrence of complication.

It should be noted that in normal-weight group the EOAI and LVMI also worsened three years later in spite of lower later mortality. The main reason may be an increase in BSA. In this study, we were informed that many people gained weight after AVR due to being less active and an improper diet. Since height changed little after operation, accumulation of weight may bring about larger BSA. It is important to instruct patients with small prosthesis to keep fit and control weight, which could certainly benefit their health after AVR.


Conclusions

This study analyzed the effects of BMI on the late mortality in patients undergoing AVR with small prosthesis. Results suggested that obesity was associated with increased late mortality after AVR in patients with implantation of small aortic prosthesis (size ≤ 21). Obesity and being overweight may also affect the NYHA function in the long term. EOAI should be improved where possible as it may reduce late mortality and improve life quality in such patients.


Abbreviations

AVR: Aortic valve replacement; BMI: Body mass index; NYHA: New York Heart Association; LVEF: Left ventricular ejection fraction; EOAI: Effective orifice area index; LVMI: Left ventricular mass index; PPM: Patient-prosthesis mismatch; AF: Atrial fibrillation; CABG: Coronary artery bypass graft; CPB: Cardiopulmonary bypass.


Competing interests

The authors declare that they have no competing interests.


Authors’ contributions

This study was designed by BW and SW. BW and HY drafted the manuscript. All authors participated in the Data collection and compilation. GC and HY performed the statistical analysis. All authors read and approved the final manuscript.


References
Nicks R,Cartmill T,Bernstein L,Hypoplasia of the aortic root. The problem of aortic valve replacementThoraxYear: 1970833934610.1136/thx.25.3.3395452289
Manouguian S,Seybold-Epting W,Patch enlargement of the aortic valve ring by extending the aortic incisions into the anterior mitral leaflet. New operative techniqueJ Thorac Cardiovasc SurgYear: 19798402412470420
Konno S,Imai Y,Iida Y,Nakajima M,Tatsuno K,A new method for prosthetic valve replacement in congenital aortic stenosis associated with hypoplasia of the aortic valve ringJ Thorac Cardiovasc SurgYear: 19758909917127094
Shibata KE,Abe T,Sekine S,Chanda J,Suprannular aortic root enlargement in patients with small aortic annulus: efficacy and safetyAnn Thorac Cardiovasc SurgYear: 199882622659828283
Sommers KE,David TE,Aortic valve replacement with patch enlargement of the aortic annulusAnn Thorac SurgYear: 199781608161210.1016/S0003-4975(97)00127-69205157
Walther T,Falk V,Langebartels G,Regression of left ventricular hypertrophy after stentless versus conventiaonal aortic valve replacementSemin Thorac Cardiovasc SurgYear: 19998182110660161
Rao V,Christakis GT,Weisel RD,Changing pattern of valve surgeryCirculationYear: 1996811312010.1161/01.CIR.94.1.1138964111
Abdelnoor M,Hall KV,Nitter-Hauge S,Linderberg H,Ovrum E,Prognostic factors in aortic valve replacement associated with narrow aortic rootsScand J Thorac Cardiovasc SurgYear: 1986822723210.3109/140174386091059293810091
Wang Y,Mi J,Shan XY,Wang QJ,Ge KY,Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in ChinaInt J ObesYear: 2007817718810.1038/sj.ijo.0803354
Zhou BF,Cooperative meta-analysis group of the working group on obesity in China predictive values of body mass index and waist circumference for risk factors of certain related diseases in chinese adults—study on optimal cut-off points of body mass index and waist circumference in vhinese adultsBiomed Environ SciYear: 20028839612046553
Parwis BR,David HA,Javier GC,Joanna C,Carol A,Bodian D,Impact of Body Mass Index on Early Outcome and Late Survival in Patients Undergoing Coronary Artery Bypass Grafting or Valve Surgery or BothAm J CardiolYear: 200781702170810.1016/j.amjcard.2007.07.01718036372
William CR,Carey CR,Travis JV,Effect of body mass index on survival in patients having aortic valve replacement for aortic stenosis with or without concomitant coronary artery bypass graftingAm J CardiolYear: 201181767177110.1016/j.amjcard.2011.09.01021996142
Vinod HT,W Brent K,Patrick DK,John DP,Omar ML,Edward PC,The impact of body mass index on morbidity and short- and long-term mortality in cardiac valvular surgeryJ Thorac Cardiovasc SurgYear: 201181052106110.1016/j.jtcvs.2011.02.00921450310
Robert L,Smith II,Morley AH,Does Body Mass Index Affect Outcomes for Aortic Valve Replacement Surgery for Aortic StenosisAnn Thorac Cardiovasc SurgYear: 20128742747
Per K,Reinhold B,Lars-Gunnar H,Observed and relative survival after aortic valve replacementJ Am Coll CardiolYear: 2000874775610.1016/S0735-1097(99)00584-710716479
Jeremy JP,Michael SL,Mohammad B,Imran F,Eugene HB,William JS,Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunctionJ Am Coll CardiolYear: 200281356136310.1016/S0735-1097(02)01759-X11955855
Mohty D,Malouf JF,Girard SE,Impact of prosthesis-patient mismatch on long-term survival in patients with small St. Jude medical mechanical prostheses in the aortic positionCirculationYear: 2006842042610.1161/CIRCULATIONAHA.105.54675416415379
Dania M,Jean GD,Najmeddine E,Impact of mpact of prosthesis-patient mismatch on long-term survival after aortic valve replacementJ Am Coll CardiolYear: 20098394710.1016/j.jacc.2008.09.02219118723
Tasca G,Mhagna Z,Perotti S,Impact of prosthesis-patient mismatch on cardiac events and midterm mortality after aortic valve replacement in patients with pure aortic stenosisCirculationYear: 2006857057610.1161/CIRCULATIONAHA.105.58702216401767
Moon MR,Pasque MK,Munfakh NA,Prosthesis-patient mismatich after aortic valve replacement: impact of age and body size on late survivalAnn Thorac SurgYear: 2006848148810.1016/j.athoracsur.2005.07.08416427836
Dumesnil JG,Honos GN,Lemieux M,Beauchemin J,Validation and applications of indexed aortic prosthetic valve areas calculated by Doppler echocardiographyJ Am Coll CardiolYear: 1990863764310.1016/0735-1097(90)90355-S2387937
Florian B,Walter BE,Sabine B,Ralf G,Inam W,Robert B,Hemodynamic comparison of bioprostheses for complete supra-annular position in patients with small aortic annulusJ Am Coll CardiolYear: 200582054206010.1016/j.jacc.2005.03.03915963409
Ina MW,Walter BE,Sabine B,Influence of completely supra-annular placement of bioprosthesisi on exercise hemodynamics in patients with a small aortic annulusJ Thorac Cardiovasc SurgYear: 200781234124110.1016/j.jtcvs.2006.10.07417467435
Sandro G,Giorgio M,Romeo F,Paolo DC,Rocco C,Ugohho L,Usefulness of the cryolife O’Brien stentless suprannular aortic valve to prevent prosthesis-patient mismatich in the small aortic rootJ Am Coll CardiolYear: 200281845185110.1016/S0735-1097(02)01861-212039501
A Marc G,Eugene HB,Joan MA,The carbomedics Top hat supraannular aortic valve: a multicenter studyAnn Thorac SurgYear: 200381175118010.1016/S0003-4975(02)03991-712683558
Hany E,Predicting complication of top hat prosthesis in aortic valve replacement: suspicion can save livesAnn Thorac SurgYear: 2009867667719161825
Suzanne R,Marin C,Jan N,Mechanical aortic valve prosthesis in the small aortic root: top-hat versus standard Carbomedics aortic valveAnn Thorac SurgYear: 20088647010.1016/j.athoracsur.2008.01.08518573400
Molina JE,Enlargement of aortic annulus using a double-patch technique: a safe and effective methodAnn Thorac SurgYear: 2002866767010.1016/S0003-4975(01)03403-811845904
David H,Obesity and diabetes: the links and common approachesPrim Care DiabetesYear: 2010810511210.1016/j.pcd.2010.04.00220447884
Chuang SY,Chou P,Hsu PF,Presence and progression of abdominal obesity are predictor of future high blood pressure and hypertensionAm J HypertensYear: 2006878879510.1016/j.amjhyper.2006.01.01016876676
Ninh TN,Xuan-M TN,James BW,Johnathan AS,John SL,Association of obesity with risk of coronary heart disease: findings from the National health and nutrition examination survey, 1999-2006Surg Obes Relat DisYear: 2010846546910.1016/j.soard.2010.02.03820870177
Auer J,Weber T,Berent R,Obesity, body fat and coronary atherosclerosisInt J CardiolYear: 2005822723510.1016/j.ijcard.2003.11.00715686772
Eleonora DG,Tiffany G,Lydia W,Population attributable risk (PAR) of overweight and obesity on chronic disease:south Australian representative, cross-sectional data, 2004-2006Obes Res and Clin PractYear: 2009815916810.1016/j.orcp.2009.03.004
Will RR,Janet BM,Epidemiology of obesity and chronic kidney diseaseAdv Chronic Kidney DisYear: 2006840341710.1053/j.ackd.2006.07.00817045226
Zuzanna P,Federico PC,Wim V,Association of overweight and obesity with interest in healthy eating, subjective health and perceived risk of chronic diseases in three European countriesAppetiteYear: 20098399406
Bloomstein LZ,Gielchinsky I,Bernstein AD,Parsonnet B,Saunders C,Karanam T,Aortic valve replacement in geriatric patients: determinants of in-hospital mortalityAnn Thorac SurgYear: 2001859760010.1016/S0003-4975(00)02326-211235713

Figures

[Figure ID: F1]
Figure 1 

Overall survival and separate survival of three groups divided by body mass group (BMI). Blue indicates normal group (BMI < 24 kg/m2); green indicates overweight group (BMI 24–27.9 kg/m2); red line indicates obesity group (BMI ≥ 28 kg/m2). A Overall survival %. B Separate suvival %.



Tables
[TableWrap ID: T1] Table 1 

Baseline pre-operative and operative data of total study groups in patients who survive the first postoperative month after AVR


 
BMI < 24
24 ≤ BMI ≤ 27.9
BMI ≥ 28
  n = 185 n = 94 n = 28
Age, y
56 ± 11.5
54 ± 14.7
57.8 ± 10.3
Sex (female),n (%)
116 (64.4)
44 (47.3)*
19 (67.8)†
Body surface area,m2
1.72 ± 0.32
1.78 ± 0.21*
1.86 ± 0.28*†
NYHA functional class, n (%)
 
 
 
  III
85 (45.9)
36 (38.3)
13 (46.4)
  IV
66 (35.7)
28 (29.8)
8 (28.6)
LVEF, %
49.6 ± 9.2
52.7 ± 7.8
51.8 ± 8.1
Pathology, n (%)
 
 
 
  Stenosis
64 (34.6)
26 (27.6)
8 (28.6)
  Insufficiency
20 (10.8)
12 (12.8)
6 (21.4)*†
  Mixed
101 (54.6)
56 (59.6)
14 (50)
Diabetes mellitus, n (%)
26 (14.1)
20 (21.2)*
8 (28.6)*†
Systemic hypertension, n (%)
41 (22.1)
28 (29.8)*
13 (46.4)*†
Chronic lung disease, n (%)
21 (11.4)
15 (15.9)*
6 (21.4)*†
AF, n (%)
75 (40.5)
28 (29.8)*
9 (32.7)*
Operative data
 
 
 
  Concomitant CABG
30 (16.2)
18 (19.1)*
6 (21.4)*†
  EOAI,cm2/m2
1.07 ± 0.12
0.96 ± 0.08*
0.81 ± 0.05*†
  CPB time, min
100 ±31
104 ± 42
112 ± 28*†
  Mechanical prosthesis, % 126 (68.5) 54 (57.4) 16 (57.1)

*significant difference from normal (BMI < 24) group; † significant difference from overweight (24 ≤ BMI ≤ 27.9) group.

Abbreviations: AVR Aortic valve replacement, BMI Basic mass index, NS Not significant, NYHA New York Heart Association, LVEF Left ventricular eject fraction, AF Atrial fibrillation, CABG Coronary artery bypass graft, EOAI Effective orifice area index, CPB Cardiopulmonary bypass.


[TableWrap ID: T2] Table 2 

Results of univariate and multivariate analyses based on observed late (deaths within 30 days of aortic valve replacement excluded) survival using the cox regression


 
Univariate analysis
Multivariate analysis 2
  p Value HR (95% CI) p Value HR (95% CI)
Age
p < 0.001
1.34(1.12-1.58)
p < 0.001
1.21(1.04-1.10)
Sex
0.08
0.92(0.72-1.14)
0.21
0.89(0.84-0.95)
Body surface area
NS
1.34(1.14-1.53)
0.75
1.29(1.10-1.50)
NYHA functional calss III/IV
p < 0.001
1.25(1.04-1.47)
0.48
1.22(1.01-1.43)
LVEF
p < 0.001
1.58(1.12-2.06)
p < 0.001
1.28(1.09-1.51)
Predominant AS
0.05
1.11(0.84-1.40)
0.43
1.04(0.86-1.24)
Diabetes mellitus
p < 0.001
1.21(1.02-1.12)
0.01
1.02(0.75-1.32)
Systemic hypertension
p < 0.001
1.43(0.14-1.78)
p < 0.001
1.20(0.87-1.53)
Chronic lung disease
p < 0.001
1.39(1.20-1.63)
0.003
1.30(1.03-1.60)
AF
p < 0.001
1.27(1.04-1.56)
0.12
1.16(0.89-1.48)
Operative data
 
 
 
 
Concomitant CABG
0.004
1.10(0.96-1.26)
0.11
1.02(0.90-1.15)
EOAI ≤ 0.85 cm2/m2
p < 0.001
1.42(1.12-1.73)
0.005
1.26(1.09-1.44)
Mechanical prosthesis
0.03
1.17(0.94-1.42)
0.08
0.88(0.65-1.10)
24 ≤ BMI ≤ 27.9
0.01
0.92(0.71-1.15)
0.34
0.68(0.50-0.92)
BMI ≥ 28
p < 0.001
1.84(1.46-2.26)
0.01
1.62(1.33-1.93)
Propensity score 0.75 1.51(1.18-1.94) 0.53 1.73(1.34-2.12)

Bold indicates statistical significance on multivariate analysis. Analysis 1: without adjustment for propensity score. Analysis 2: with adjustment for propensity score. CI, Confidence interval; HR, Hazard ratio; AS, Aortic stenosis; BMI, Body mass index; other abbreviations as in Table 1.



Article Categories:
  • Research Article

Keywords: Aortic valve replacement, Small aortic root, Obesity, Body mass index.

Previous Document:  Colonized Aedes albopictus and its sexual performance in the wild: implications for SIT technology a...
Next Document:  Chinese plasma-derived products supply under the lot release management system in 2007-2011.